TS622950522	sideeffect 709 720	interaction
TS922950522	drug 738 750	methotrexate
TS2522950522	sideeffect 1356 1383	pharmacokinetic interaction
TS2222950522	drug 1405 1417	methotrexate
TS2122950522	drugEffect 1516 1531	bioavailability
TS1022950522	food 1679 1683	food
TS222950522	food 2786 2790	Food
TS1122950522	drugEffect 2805 2820	bioavailability
TS422950522	drug 2916 2928	methotrexate
TS522950522	drug 3019 3031	methotrexate
TS122950522	sideeffect 3270 3297	gastrointestinal discomfort
T1	drug 48 56	GLPG0259
T2	drug 112 151;61 78	protein kinase 5 ( MAPKAPK5 ) inhibitor mitogen-activated
T3	drug 216 224	GLPG0259
T4	drug 245 275;309 338	inhibitor of mitogen-activated protein kinase 5 ( MAPKAPK5 )
T5	drug 724 732	GLPG0259
T6	drug 558 566	GLPG0259
R1	has_sideeffect Arg1:T5 Arg2:TS622950522	
R2	has_sideeffect Arg1:TS922950522 Arg2:TS622950522	
T7	dosage 947 957	1.5-150 mg
T8	modeadm 973 977	oral
T9	dosage 986 998	20 and 50 mg
T10	frequency 999 1009	once daily
T11	drug 1015 1023	GLPG0259
T12	drug 1226 1234	GLPG0259
T13	dosage 1237 1245	25-75 mg
T14	frequency 1246 1256	once daily
T15	duration 1265 1276	for 14 days
T16	drug 1392 1400	GLPG0259
T17	drug 1561 1569	GLPG0259
T18	dosage 1621 1627	100 mg
T19	dosage 1631 1636	50 mg
T20	frequency 1637 1648	single dose
T21	drug 1812 1820	GLPG0259
T22	drug 1881 1889	GLPG0259
T23	drug 2092 2100	GLPG0259
T24	drug 2343 2351	GLPG0259
T25	dosage 2395 2404	30-150 mg
T26	dosage 2429 2437	25-75 mg
T27	food 2405 2416	single-dose
T28	frequency 2438 2451	repeated-dose
T29	drug 2503 2511	GLPG0259
T30	frequency 2596 2606	once-daily
T31	drug 2774 2782	GLPG0259
T32	drug 2824 2832	GLPG0259
R3	increase_absorption Arg1:TS222950522 Arg2:T32	
T33	drug 2885 2893	GLPG0259
T34	dosage 2929 2935	7.5 mg
T35	drug 3007 3015	GLPG0259
T36	drug 3182 3190	GLPG0259
T37	sideeffect 3238 3251	adverse event
